News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Odronextamab plus chemo safe as DLBCL treatment, with promising efficacy
16 Jan 2026
byStephen Padilla
Combination treatment with the CD20×CD3 bispecific antibody odronextamab and chemotherapy is generally safe among previously untreated diffuse large B cell lymphoma (DLBCL) patients, without new safety signals, as shown by the results from part 1 of the phase III Olympia-3 study.
Odronextamab plus chemo safe as DLBCL treatment, with promising efficacy
16 Jan 2026
Maternal asthma may raise congenital heart defect risk in offspring
15 Jan 2026
byStephen Padilla
Asthma and allergic tendency in mothers appear to elevate the risk of congenital heart defect (CHD) in their children, suggests a study, noting that nonallergic asthma also contributes to such risk.







